04/12/2023

BVI Quarterly Corporate Update Q1 2023

It has also been a busy time on the BVI transactional front with our corporate team advising on some of the most notable transactions in the jurisdiction.

03/31/2023

Christopher Cowles featured in Life Sciences IP Review

The article discusses the recent, highly anticipated US Supreme Court hearings between Amgen and Sanofi, two pharmaceutical companies, regarding the true definition and test of “enablement” under Section 112 of the US Patent Act.